Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3TBR
|
||||
| Drug Name |
19-methyl-3-(2-methylpropyl)-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-14-one
|
||||
| Synonyms |
CHEMBL270827
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H24N4O
|
||||
| Canonical SMILES |
CC(C)Cn1c2ccccc2c3c4CNC(=O)c4c5c(CCc6nn(C)cc56)c13
|
||||
| InChI |
InChI=1S/C24H24N4O/c1-13(2)11-28-19-7-5-4-6-14(19)21-16-10-25-24(29)22(16)20-15(23(21)28)8-9-18-17(20)12-27(3)26-18/h4-7,12-13H,8-11H2,1-3H3,(H,25,29)
|
||||
| InChIKey |
ILXVDMYISRLVIY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.